Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Familial aggregation of childhood and adulthood-onset Systemic Lupus Erythematosus.

Sinicato NA, de Oliveira L, Lapa AT, Postal M, de Oliveira Peliçari K, Costallat LTL, Marini R, Gil-da-Silva-Lopes VL, Niewold TB, Appenzeller S.

Arthritis Care Res (Hoboken). 2019 May 25. doi: 10.1002/acr.23931. [Epub ahead of print]

PMID:
31127864
2.

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.

Oke V, Gunnarsson I, Dorschner J, Eketjäll S, Zickert A, Niewold TB, Svenungsson E.

Arthritis Res Ther. 2019 Apr 29;21(1):107. doi: 10.1186/s13075-019-1878-y.

3.

When pregnancy tames the wolf.

Niewold TB, Mehta-Lee S.

J Exp Med. 2019 May 6;216(5):1012-1013. doi: 10.1084/jem.20190378. Epub 2019 Apr 8.

4.

Novel genetic associations with interferon in systemic lupus erythematosus identified by replication and fine-mapping of trait-stratified genome-wide screen.

Ghodke-Puranik Y, Imgruet M, Dorschner JM, Shrestha P, McCoy K, Kelly JA, Marion M, Guthridge JM, Langefeld CD, Harley JB, James JA, Sivils KL, Niewold TB.

Cytokine. 2019 Jan 23. pii: S1043-4666(19)30002-X. doi: 10.1016/j.cyto.2018.12.014. [Epub ahead of print]

PMID:
30685201
5.

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, Tsuchiya N, Rojas-Serrano J, González-Pérez MI, Mejía M, Buendía-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou K, van Moorsel CHM, van der Vis J, de Man YA, Grutters JC, Wang Y, Borie R, Wemeau-Stervinou L, Wallaert B, Flipo RM, Nunes H, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Marchand-Adam S, Frazier A, Richette P, Allanore Y, Sibilia J, Dromer C, Richez C, Schaeverbeke T, Lioté H, Thabut G, Nathan N, Amselem S, Soubrier M, Cottin V, Clément A, Deane K, Walts AD, Fingerlin T, Fischer A, Ryu JH, Matteson EL, Niewold TB, Assayag D, Gross A, Wolters P, Schwarz MI, Holers M, Solomon JJ, Doyle T, Rosas IO, Blauwendraat C, Nalls MA, Debray MP, Boileau C, Crestani B, Schwartz DA, Dieudé P.

N Engl J Med. 2018 Dec 6;379(23):2209-2219. doi: 10.1056/NEJMoa1801562. Epub 2018 Oct 20.

6.

Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus.

Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang X, Tomar D, Woodruff MC, Simon Z, Bugrovsky R, Blalock EL, Scharer CD, Tipton CM, Wei C, Lim SS, Petri M, Niewold TB, Anolik JH, Gibson G, Lee FE, Boss JM, Lund FE, Sanz I.

Immunity. 2018 Oct 16;49(4):725-739.e6. doi: 10.1016/j.immuni.2018.08.015. Epub 2018 Oct 9.

7.

Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid Arthritis.

Titcombe PJ, Wigerblad G, Sippl N, Zhang N, Shmagel AK, Sahlström P, Zhang Y, Barsness LO, Ghodke-Puranik Y, Baharpoor A, Hansson M, Israelsson L, Skriner K, Niewold TB, Klareskog L, Svensson CI, Amara K, Malmström V, Mueller DL.

Arthritis Rheumatol. 2018 Dec;70(12):1933-1945. doi: 10.1002/art.40590. Epub 2018 Oct 18.

PMID:
29927106
8.

A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus.

Patel ZH, Lu X, Miller D, Forney CR, Lee J, Lynch A, Schroeder C, Parks L, Magnusen AF, Chen X, Pujato M, Maddox A, Zoller EE, Namjou B, Brunner HI, Henrickson M, Huggins JL, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath SK, Stevens AM, Freedman BI, Pons-Estel BA, Tsao BP, Jacob CO, Kamen DL, Brown EE, Gilkeson GS, Alarcón GS, Martin J, Reveille JD, Anaya JM, James JA, Sivils KL, Criswell LA, Vilá LM, Petri M, Scofield RH, Kimberly RP, Edberg JC, Ramsey-Goldman R, Bang SY, Lee HS, Bae SC, Boackle SA, Cunninghame Graham D, Vyse TJ, Merrill JT, Niewold TB, Ainsworth HC, Silverman ED, Weisman MH, Wallace DJ, Raj P, Guthridge JM, Gaffney PM, Kelly JA, Alarcón-Riquelme ME, Langefeld CD, Wakeland EK, Kaufman KM, Weirauch MT, Harley JB, Kottyan LC.

Hum Mol Genet. 2018 Jul 1;27(13):2392-2404. doi: 10.1093/hmg/ddy140.

9.

The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry.

Goulielmos GN, Zervou MI, Vazgiourakis VM, Ghodke-Puranik Y, Garyfallos A, Niewold TB.

Gene. 2018 Aug 20;668:59-72. doi: 10.1016/j.gene.2018.05.041. Epub 2018 May 25. Review.

PMID:
29775752
10.

Type I interferon in rheumatic diseases.

Muskardin TLW, Niewold TB.

Nat Rev Rheumatol. 2018 Mar 21;14(4):214-228. doi: 10.1038/nrrheum.2018.31. Review.

11.

Associations between type I interferon and antiphospholipid antibody status differ between ancestral backgrounds.

Iwamoto T, Dorschner J, Jolly M, Huang X, Niewold TB.

Lupus Sci Med. 2018 Jan 13;5(1):e000246. doi: 10.1136/lupus-2017-000246. eCollection 2018.

12.

Increased Whole Blood Viscosity Is Associated with the Presence of Digital Ulcers in Systemic Sclerosis: Results from a Cross-Sectional Pilot Study.

Korsten P, Niewold TB, Zeisberg M, Utset TO, Cho D, Zachary LS, Sweiss NJ, Volkov S.

Autoimmune Dis. 2017;2017:3529214. doi: 10.1155/2017/3529214. Epub 2017 Nov 29.

13.

Single-cell gene expression patterns in lupus monocytes independently indicate disease activity, interferon and therapy.

Jin Z, Fan W, Jensen MA, Dorschner JM, Bonadurer GF 3rd, Vsetecka DM, Amin S, Makol A, Ernste F, Osborn T, Moder K, Chowdhary V, Niewold TB.

Lupus Sci Med. 2017 Jun 25;4(1):e000202. doi: 10.1136/lupus-2016-000202. eCollection 2017. Erratum in: Lupus Sci Med. 2017 Sep 11;4(1):e000202corr1.

14.

Predictors of changes in disease activity among children with juvenile dermatomyositis enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry.

Challa D, Crowson CS, Niewold TB, Reed AM; CARRA Legacy Registry Investigators.

Clin Rheumatol. 2018 Apr;37(4):1011-1015. doi: 10.1007/s10067-017-3901-5. Epub 2017 Nov 23.

PMID:
29170979
15.

Brief Report: A Novel ELANE Mutation Associated With Inflammatory Arthritis, Defective NETosis, and Recurrent Parvovirus Infection.

Thanarajasingam U, Jensen MA, Dorschner JM, Wampler Muskardin T, Ghodke-Puranik Y, Purmalek M, Eliopoulos E, Zervou MI, Goulielmos GN, Howard M, Kaplan MJ, Niewold TB.

Arthritis Rheumatol. 2017 Dec;69(12):2396-2401. doi: 10.1002/art.40314. Epub 2017 Nov 8.

16.

Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells.

Ghodke-Puranik Y, Dorschner JM, Vsetecka DM, Amin S, Makol A, Ernste F, Osborn T, Moder K, Chowdhary V, Eliopoulos E, Zervou MI, Goulielmos GN, Jensen MA, Niewold TB.

Arthritis Rheumatol. 2017 Dec;69(12):2328-2337. doi: 10.1002/art.40304. Epub 2017 Nov 9.

17.

Defining biological subsets in systemic lupus erythematosus: progress toward personalized therapy.

Sinicato NA, Postal M, Appenzeller S, Niewold TB.

Pharmaceut Med. 2017 Apr;31(2):81-88. doi: 10.1007/s40290-017-0178-6. Epub 2017 Jan 25.

18.

By CyTOF: Heterogeneity of Human Monocytes.

Loke P, Niewold TB.

Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1423-1424. doi: 10.1161/ATVBAHA.117.309645. No abstract available.

19.

Transancestral mapping and genetic load in systemic lupus erythematosus.

Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA, Bijl M, Brown EE, Brunner HI, Cardiel MH, Catoggio L, Cervera R, Cucho-Venegas JM, Dahlqvist SR, D'Alfonso S, Da Silva BM, de la Rúa Figueroa I, Doria A, Edberg JC, Endreffy E, Esquivel-Valerio JA, Fortin PR, Freedman BI, Frostegård J, García MA, de la Torre IG, Gilkeson GS, Gladman DD, Gunnarsson I, Guthridge JM, Huggins JL, James JA, Kallenberg CGM, Kamen DL, Karp DR, Kaufman KM, Kottyan LC, Kovács L, Laustrup H, Lauwerys BR, Li QZ, Maradiaga-Ceceña MA, Martín J, McCune JM, McWilliams DR, Merrill JT, Miranda P, Moctezuma JF, Nath SK, Niewold TB, Orozco L, Ortego-Centeno N, Petri M, Pineau CA, Pons-Estel BA, Pope J, Raj P, Ramsey-Goldman R, Reveille JD, Russell LP, Sabio JM, Aguilar-Salinas CA, Scherbarth HR, Scorza R, Seldin MF, Sjöwall C, Svenungsson E, Thompson SD, Toloza SMA, Truedsson L, Tusié-Luna T, Vasconcelos C, Vilá LM, Wallace DJ, Weisman MH, Wither JE, Bhangale T, Oksenberg JR, Rioux JD, Gregersen PK, Syvänen AC, Rönnblom L, Criswell LA, Jacob CO, Sivils KL, Tsao BP, Schanberg LE, Behrens TW, Silverman ED, Alarcón-Riquelme ME, Kimberly RP, Harley JB, Wakeland EK, Graham RR, Gaffney PM, Vyse TJ.

Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021.

20.

Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date.

Lenert A, Niewold TB, Lenert P.

Drug Des Devel Ther. 2017 Mar 13;11:747-757. doi: 10.2147/DDDT.S114552. eCollection 2017. Review.

21.

CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus.

Faridi MH, Khan SQ, Zhao W, Lee HW, Altintas MM, Zhang K, Kumar V, Armstrong AR, Carmona-Rivera C, Dorschner JM, Schnaith AM, Li X, Ghodke-Puranik Y, Moore E, Purmalek M, Irizarry-Caro J, Zhang T, Day R, Stoub D, Hoffmann V, Khaliqdina SJ, Bhargava P, Santander AM, Torroella-Kouri M, Issac B, Cimbaluk DJ, Zloza A, Prabhakar R, Deep S, Jolly M, Koh KH, Reichner JS, Bradshaw EM, Chen J, Moita LF, Yuen PS, Li Tsai W, Singh B, Reiser J, Nath SK, Niewold TB, Vazquez-Padron RI, Kaplan MJ, Gupta V.

J Clin Invest. 2017 Apr 3;127(4):1271-1283. doi: 10.1172/JCI88442. Epub 2017 Mar 6.

22.

Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.

Zervou MI, Dorschner JM, Ghodke-Puranik Y, Boumpas DT, Niewold TB, Goulielmos GN.

Gene. 2017 Apr 30;610:9-14. doi: 10.1016/j.gene.2017.02.003. Epub 2017 Feb 6.

PMID:
28185859
23.

Dynamics of pulse wave velocity and vascular augmentation index in association with endothelial progenitor cells in SLE.

Korsten P, Patschan D, Henze E, Niewold TB, Müller GA, Patschan S.

Lupus Sci Med. 2016 Dec 23;3(1):e000185. doi: 10.1136/lupus-2016-000185. eCollection 2016.

24.

Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features.

Munroe ME, Young KA, Kamen DL, Guthridge JM, Niewold TB, Costenbader KH, Weisman MH, Ishimori ML, Wallace DJ, Gilkeson GS, Karp DR, Harley JB, Norris JM, James JA.

Arthritis Rheumatol. 2017 Mar;69(3):630-642. doi: 10.1002/art.40004.

25.

Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult Dermatomyositis.

López De Padilla CM, Crowson CS, Hein MS, Pendegraft RS, Strausbauch MA, Niewold TB, Ernste FC, Peterson E, Baechler EC, Reed AM.

J Rheumatol. 2017 Jan;44(1):117-124. doi: 10.3899/jrheum.160293. Epub 2016 Nov 1.

26.

Elevated procalcitonin levels in a severe lupus flare without infection.

Wallbach M, Vasko R, Hoffmann S, Niewold TB, Müller GA, Korsten P.

Lupus. 2016 Dec;25(14):1625-1626. Epub 2016 May 22. No abstract available.

PMID:
27216419
27.

Genetics of human lupus nephritis.

Iwamoto T, Niewold TB.

Clin Immunol. 2017 Dec;185:32-39. doi: 10.1016/j.clim.2016.09.012. Epub 2016 Sep 28. Review.

28.

Differential Expression of miR-4520a Associated With Pyrin Mutations in Familial Mediterranean Fever (FMF).

Latsoudis H, Mashreghi MF, Grün JR, Chang HD, Stuhlmüller B, Repa A, Gergiannaki I, Kabouraki E, Vlachos GS, Häupl T, Radbruch A, Sidiropoulos P, Doukoumetzidis K, Kardassis D, Niewold TB, Boumpas DT, Goulielmos GN.

J Cell Physiol. 2017 Jun;232(6):1326-1336. doi: 10.1002/jcp.25602. Epub 2016 Dec 20.

PMID:
27636101
29.

Manifestations of systemic lupus erythematosus in female patients with polysomy X: Possible roles of chromosome X.

Iwamoto T, Fujimoto M, Ikeda K, Saku A, Makita S, Furuta S, Niewold TB, Nakajima H.

Mod Rheumatol. 2019 Jan;29(1):192-194. doi: 10.1080/14397595.2016.1205800. Epub 2016 Jul 12.

PMID:
27401488
30.

Incidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria.

Ungprasert P, Sagar V, Crowson CS, Amin S, Makol A, Ernste FC, Osborn TG, Moder KG, Niewold TB, Maradit-Kremers H, Ramsey-Goldman R, Chowdhary VR.

Lupus. 2017 Mar;26(3):240-247. doi: 10.1177/0961203316657434. Epub 2016 Jul 11.

31.

Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus.

Young KA, Munroe ME, Guthridge JM, Kamen DL, Niewold TB, Gilkeson GS, Weisman MH, Ishimori ML, Kelly J, Gaffney PM, Sivils KH, Lu R, Wallace DJ, Karp DR, Harley JB, James JA, Norris JM.

Ann Rheum Dis. 2017 Jan;76(1):153-158. doi: 10.1136/annrheumdis-2016-209157. Epub 2016 Jun 9.

32.

Connective tissue diseases: Targeting type I interferon in systemic lupus erythematosus.

Niewold TB.

Nat Rev Rheumatol. 2016 Jul;12(7):377-8. doi: 10.1038/nrrheum.2016.83. Epub 2016 May 26. No abstract available.

PMID:
27225301
33.

Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.

Munroe ME, Lu R, Zhao YD, Fife DA, Robertson JM, Guthridge JM, Niewold TB, Tsokos GC, Keith MP, Harley JB, James JA.

Ann Rheum Dis. 2016 Nov;75(11):2014-2021. doi: 10.1136/annrheumdis-2015-208140. Epub 2016 Jan 25.

34.

Drugs in early clinical development for Systemic Lupus Erythematosus.

Postal M, Sinicato NA, Appenzeller S, Niewold TB.

Expert Opin Investig Drugs. 2016;25(5):573-83. doi: 10.1517/13543784.2016.1162291. Epub 2016 Apr 7. Review.

35.

Genetic data: The new challenge of personalized medicine, insights for rheumatoid arthritis patients.

Goulielmos GN, Zervou MI, Myrthianou E, Burska A, Niewold TB, Ponchel F.

Gene. 2016 Jun 1;583(2):90-101. doi: 10.1016/j.gene.2016.02.004. Epub 2016 Feb 8. Review.

36.

Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production.

Deng Y, Zhao J, Sakurai D, Sestak AL, Osadchiy V, Langefeld CD, Kaufman KM, Kelly JA, James JA, Petri MA, Bae SC, Alarcón-Riquelme ME, Alarcón GS, Anaya JM, Criswell LA, Freedman BI, Kamen DL, Gilkeson GS, Jacob CO, Merrill JT, Gaffney PM, Sivils KM, Niewold TB, Ramsey-Goldman R, Reveille JD, Scofield RH, Stevens AM, Boackle SA, Vilá LM, Sohn II, Lee S, Chang DM, Song YW, Vyse TJ, Harley JB, Brown EE, Edberg JC, Kimberly RP, Cantor RM, Hahn BH, Grossman JM, Tsao BP.

Ann Rheum Dis. 2016 Nov;75(11):2007-2013. doi: 10.1136/annrheumdis-2015-208441. Epub 2016 Jan 18.

37.

Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis.

Ghodke-Puranik Y, Puranik AS, Shintre P, Joshi K, Patwardhan B, Lamba J, Niewold TB, Chopra A.

Pharmacogenomics. 2015 Dec;16(18):2019-34. doi: 10.2217/pgs.15.145. Epub 2015 Nov 30.

38.

Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis.

Wampler Muskardin T, Vashisht P, Dorschner JM, Jensen MA, Chrabot BS, Kern M, Curtis JR, Danila MI, Cofield SS, Shadick N, Nigrovic PA, St Clair EW, Bingham CO 3rd, Furie R, Robinson W, Genovese M, Striebich CC, O'Dell JR, Thiele GM, Moreland LW, Levesque M, Bridges SL Jr, Gregersen PK, Niewold TB.

Ann Rheum Dis. 2016 Oct;75(10):1757-62. doi: 10.1136/annrheumdis-2015-208001. Epub 2015 Nov 6.

39.

The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.

López de Padilla CM, Niewold TB.

Gene. 2016 Jan 15;576(1 Pt 1):14-21. doi: 10.1016/j.gene.2015.09.058. Epub 2015 Sep 26. Review.

40.

Immunological biomarkers in dermatomyositis.

Olazagasti JM, Niewold TB, Reed AM.

Curr Rheumatol Rep. 2015 Nov;17(11):68. doi: 10.1007/s11926-015-0543-y. Review.

PMID:
26404949
41.

Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus.

Zhao J, Wu H, Langefeld CD, Kaufman KM, Kelly JA, Bae SC; Marta E. Alarcón-Riquelme for the BIOLUPUS and GENLES networks, Alarcón GS, Anaya JM, Criswell LA, Freedman BI, Kamen DL, Gilkeson GS, Jacob CO, James JA, Merrill JT, Gaffney PM, Sivils KM, Niewold TB, Petri MA, Song ST, Jeong HJ, Ramsey-Goldman R, Reveille JD, Scofield RH, Stevens AM, Boackle SA, Vilá LM, Chang DM, Song YW, Vyse TJ, Harley JB, Brown EE, Edberg JC, Kimberly RP, Hahn BH, Grossman JM, Tsao BP, La Cava A.

Clin Immunol. 2015 Dec;161(2):157-62. doi: 10.1016/j.clim.2015.09.007. Epub 2015 Sep 16.

42.

Immunogenetics of systemic lupus erythematosus: A comprehensive review.

Ghodke-Puranik Y, Niewold TB.

J Autoimmun. 2015 Nov;64:125-36. doi: 10.1016/j.jaut.2015.08.004. Epub 2015 Aug 29. Review.

43.

Advances in lupus genetics.

Niewold TB.

Curr Opin Rheumatol. 2015 Sep;27(5):440-7. doi: 10.1097/BOR.0000000000000205. Review.

44.

Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations.

Sharma S, Jin Z, Rosenzweig E, Rao S, Ko K, Niewold TB.

J Autoimmun. 2015 Jun;60:51-58. doi: 10.1016/j.jaut.2015.04.002. Epub 2015 Apr 24.

45.

Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura.

Edgar CE, Terrell DR, Vesely SK, Wren JD, Dozmorov IM, Niewold TB, Brown M, Zhou F, Frank MB, Merrill JT, Kremer Hovinga JA, Lämmle B, James JA, George JN, Farris AD.

PLoS One. 2015 Feb 11;10(2):e0117614. doi: 10.1371/journal.pone.0117614. eCollection 2015.

46.

The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon.

Grimm WA, Messer JS, Murphy SF, Nero T, Lodolce JP, Weber CR, Logsdon MF, Bartulis S, Sylvester BE, Springer A, Dougherty U, Niewold TB, Kupfer SS, Ellis N, Huo D, Bissonnette M, Boone DL.

Gut. 2016 Mar;65(3):456-64. doi: 10.1136/gutjnl-2014-308735. Epub 2015 Feb 2.

47.

Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.

Martins M, Williams AH, Comeau M, Marion M, Ziegler JT, Freedman BI, Merrill JT, Glenn SB, Kelly JA, Sivils KM, James JA, Guthridge JM, Alarcón-Riquelme ME, Bae SC, Kim JH, Kim D, Anaya JM, Boackle SA, Criswell LA, Kimberly RP, Alarcón GS, Brown EE, Vilá LM, Petri MA, Ramsey-Goldman R, Niewold TB, Tsao BP, Gilkeson GS, Kamen DL, Jacob CO, Stevens AM, Gaffney PM, Harley JB, Langefeld CD, Fesel C.

Genes Immun. 2015 Mar;16(2):142-50. doi: 10.1038/gene.2014.73. Epub 2015 Jan 8.

48.

Dysregulation of antiviral helicase pathways in systemic lupus erythematosus.

Oliveira L, Sinicato NA, Postal M, Appenzeller S, Niewold TB.

Front Genet. 2014 Nov 25;5:418. doi: 10.3389/fgene.2014.00418. eCollection 2014. Review.

49.

Interferon regulatory factors: critical mediators of human lupus.

Jensen MA, Niewold TB.

Transl Res. 2015 Feb;165(2):283-95. doi: 10.1016/j.trsl.2014.10.002. Epub 2014 Oct 13. Review.

50.

Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.

Kariuki SN, Ghodke-Puranik Y, Dorschner JM, Chrabot BS, Kelly JA, Tsao BP, Kimberly RP, Alarcón-Riquelme ME, Jacob CO, Criswell LA, Sivils KL, Langefeld CD, Harley JB, Skol AD, Niewold TB.

Genes Immun. 2015 Jan-Feb;16(1):15-23. doi: 10.1038/gene.2014.57. Epub 2014 Oct 23.

Supplemental Content

Loading ...
Support Center